Modular Medical (NASDAQ: MODD) prices $3.4M registered direct stock sale
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Modular Medical, Inc. entered into a Placement Agency Agreement for a registered direct offering of 750,000 shares of common stock at $4.50 per share, for expected gross proceeds of about $3.375 million before fees and expenses.
Maxim Group LLC will act as sole placement agent, earning a 7% cash fee on gross proceeds and expense reimbursement up to $75,000. The offering is made under an effective Form S-3 shelf registration and is expected to close on or about April 21, 2026, subject to customary conditions.
Company directors and executive officers agreed to 90-day lock-up restrictions, and the Company agreed to limit additional equity issuances for 45 days after closing, subject to specified exceptions.
Positive
- None.
Negative
- None.
Insights
Modular Medical raises $3.375M via a small registered direct equity sale.
Modular Medical, Inc. is selling 750,000 shares of common stock at $4.50 per share in a registered direct offering, generating about $3.375 million in gross proceeds before fees. Maxim Group LLC serves as sole placement agent with a 7% cash fee and expense reimbursement.
The deal is conducted under an effective Form S-3 shelf registration and is expected to close around April 21, 2026, subject to customary conditions. A 90-day lock-up for directors and officers, plus a 45-day restriction on most additional equity issuances, helps stabilize the capital structure around this financing.
8-K Event Classification
3 items: 1.01, 8.01, 9.01
3 items
Item 1.01
Entry into a Material Definitive Agreement
Business
The company signed a significant contract such as a merger agreement, credit facility, or major partnership.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Shares offered: 750,000 shares
Offering price: $4.50 per share
Gross proceeds: $3.375 million
+5 more
8 metrics
Shares offered
750,000 shares
Registered direct offering of common stock
Offering price
$4.50 per share
Price for each share of common stock in the offering
Gross proceeds
$3.375 million
Expected gross proceeds before fees and expenses
Placement agent fee
7% of gross proceeds
Cash fee payable to Maxim Group LLC
Expense reimbursement cap
$75,000
Maximum reimbursable expenses to placement agent
Insider lock-up period
90 days
Lock-up on sales by directors and executive officers
Company issuance restriction
45 days
Limits on additional equity issuances after closing
Shelf registration file number
333-287313
Form S-3 registration statement used for offering
Key Terms
registered direct offering, Placement Agency Agreement, shelf registration statement, lock-up agreements, +2 more
6 terms
registered direct offering financial
"relating to a registered direct offering (the “Offering”) of 750,000 shares"
A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.
Placement Agency Agreement financial
"entered into a Placement Agency Agreement (the “Agreement”) with Maxim Group LLC"
shelf registration statement regulatory
"pursuant to a shelf registration statement on Form S-3 (File No. 333-287313)"
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
lock-up agreements financial
"each of the Company’s directors and executive officers entered into “lock-up” agreements"
A lock-up agreement is a contract that prevents company insiders—founders, employees, and early investors—from selling their shares for a set period after a public stock offering. It matters to investors because it keeps a large block of shares off the market temporarily; when the lock-up ends, those holders can sell and this increased supply can cause the stock price to fall, similar to a timed release that suddenly opens a valve.
Common Stock equivalents financial
"issuance by the Company or its subsidiaries of Common Stock or Common Stock equivalents"
Common stock equivalents are financial instruments that can be converted into common shares or have a similar effect on a company's stock ownership, such as stock options or convertible bonds. They matter to investors because they can increase the total number of shares outstanding, potentially diluting existing ownership and affecting the company's stock value. Recognizing these equivalents helps investors understand the true potential for future share issuance and company ownership structure.
forward-looking statements regulatory
"This press release contains forward-looking statements that are made pursuant"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
FAQ
What did Modular Medical (MODD) announce in this 8-K filing?
Modular Medical announced a registered direct offering of its common stock. The company entered a Placement Agency Agreement with Maxim Group LLC to sell 750,000 shares at $4.50 per share, creating roughly $3.375 million in gross proceeds before fees and offering expenses.
How much cash will Modular Medical (MODD) receive from the offering?
The company expects gross proceeds of approximately $3.375 million from the offering. This figure reflects 750,000 shares sold at $4.50 each, before deducting the 7% placement agent fee payable to Maxim Group LLC and up to $75,000 of reimbursable offering expenses.
What lock-up restrictions apply to Modular Medical’s directors and officers?
Each director and executive officer signed a 90-day lock-up agreement. These agreements generally prohibit selling, transferring, or otherwise disposing of company securities without the placement agent’s prior written consent, helping restrict insider share sales immediately following the registered direct offering.
Is Modular Medical restricted from issuing additional stock after this offering?
Yes. Under the agreement, Modular Medical agreed for 45 days from the closing date not to offer, sell, or enter agreements to issue most additional shares or common stock equivalents, subject to certain conditions and exceptions, limiting near-term additional equity issuance by the company.
Under what registration statement is Modular Medical’s offering being made?
The offering is being made under a shelf registration statement on Form S-3, File No. 333-287313. This registration statement was filed earlier and declared effective by the SEC, allowing the company to issue the registered shares via a prospectus supplement and base prospectus.